www.fdanews.com/articles/83285-mylan-announces-final-approval-for-bisoprolol-fumarate-tablets
MYLAN ANNOUNCES FINAL APPROVAL FOR BISOPROLOL FUMARATE TABLETS
December 20, 2005
Mylan Laboratories has received final FDA approval for its abbreviated new drug application for bisoprolol fumarate in 5- and 10-mg tablets. The product is the generic equivalent of Duramed Pharmaceuticals' beta-blocker Zebeta.